IBSSX | PEMGX | IBSSX / PEMGX | |
Total Expense Ratio | 1.25 | 0.91 | 137% |
Annual Report Gross Expense Ratio | 1.37 | 0.91 | 151% |
Fund Existence | 23 years | 20 years | - |
Gain YTD | -27.284 | 5.373 | -508% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 326M | 33.1B | 1% |
Annual Yield % from dividends | 0.28 | 0.00 | - |
Returns for 1 year | -27.56 | 4.13 | -668% |
Returns for 3 years | -15.68 | 54.12 | -29% |
Returns for 5 years | -30.42 | 39.26 | -77% |
Returns for 10 years | -38.88 | 105.92 | -37% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLIDX | 15.65 | N/A | N/A |
Harding Loevner Intl Dev Mkts Eq Inst | |||
FPHAX | 28.62 | N/A | N/A |
Fidelity Select Pharmaceuticals Port | |||
UTMAX | 12.03 | N/A | N/A |
Victory Target Managed Allocation | |||
GSILX | 21.81 | N/A | N/A |
Goldman Sachs GQG Ptnrs Intl Opps C | |||
DLCZX | 12.27 | -0.06 | -0.49% |
Destinations Large Cap Equity Z |